The future of pharmacovigilance: a personal view

被引:13
作者
Edwards, I. Ralph [1 ]
机构
[1] WHO, Fdn Collaborating Ctr Int Drug Monitoring, S-75320 Uppsala, Sweden
关键词
D O I
10.1007/s00228-007-0435-9
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
[No abstract available]
引用
收藏
页码:173 / 181
页数:9
相关论文
共 15 条
[1]
[Anonymous], 1990, CLIM DYNAM, DOI DOI 10.1007/BF00195850
[2]
[Anonymous], SEEING OBSERVING INT
[3]
Bate A., 2003, The use of Bayesian confidence propagation neural network in pharmacovigilance
[4]
BOWDLER J, 1997, COMMUNICATIONS PHARM, V1, P89
[5]
The WHO World Alliance for patient safety - A new challenge or an old one neglected? [J].
Edwards, IR .
DRUG SAFETY, 2005, 28 (05) :379-386
[6]
Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205
[7]
MEDAWAR C, 2004, MED OUT CONTROL ANTI, P260
[8]
MOORE N, 1985, LANCET, V2, P1056
[9]
Nelson KM, 1996, PHARMACOTHERAPY, V16, P701
[10]
NOREN GA, 2007, STAT METHODS KNOWLED, P41